Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "U.S. Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Technology, by Application, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
The U.S. radiation oncology market size is expected to reach USD 3.9 billion by 2027, expanding at a CAGR of 5.0%.
The U.S. Radiation Oncology Market Report Highlights
- External Beam Radiotherapy (EBRT) dominated the market in 2019 owing to innovation in technology used in cancer treatment and an increase in the prevalence of cancer.
- In 2019, Electron-emitting high energy linear accelerators held the largest revenue share as a result of an increase in usage due to technological revolution, an increase in capability to provide precise treatment services, and favorable reimbursement policies.
- On the basis of technology, Intensity Modulated Radiotherapy (IMRT) dominated the application segment in 2019 due to its ability to change radiation intensity during treatment so as to specifically target cancer cells and limit the damage to adjoining healthy tissues.
- In application, internal beam radiation therapy is estimated to witness the fastest growth rate during the forecast period owing to the cost-effectiveness and accuracy of brachytherapy.
Increasing the prevalence of cancer and technological advancements in radiation oncology are some of the key factors responsible for market growth.
Advancements in technologies are anticipated to reduce the adverse effects of radiotherapy and improve its overall quality. In addition, newer therapies tend to be more efficient than their traditional counterparts. For instance, SBRT was found to be efficient in treating laryngeal cancer with only five treatment fractions, as per a clinical trial that is expected to be completed by 2021.
Advancements in radiation oncology can enable the delivery of a high dose to a target area without any damage to adjacent healthy tissues. This has increased the chances of localized tumor control and improved cure rates, leading to an increase in demand for the therapy. Therefore, hospitals and ambulatory healthcare providers are installing more equipment, which, in turn, is boosting the market growth.
For instance, according to OECD, in the U.S., the number of radiotherapy equipment, which included linear accelerators, Caesium-137 therapy units, Cobalt-60 units, HDR and LDR brachytherapy units, and conventional brachytherapy units, was 11.7 per 1000,000 inhabitants in 2019.
In addition, increasing radiotherapy centers in the U.S. is anticipated to boost market growth. In January 2020, the University of Alabama at Birmingham inaugurated its proton therapy center of Proton International. The center was formed through a partnership between Proton International and the UAB. Out of 36 proton cancer centers in the U.S., Proton International at UAB was the first facility opened in Alabama.
The high adoption of cyclotrons is anticipated to drive the market. For instance, in March 2019, the University of Alabama at Birmingham installed a 90-ton cyclotron in its proton therapy center. Installation of a cyclotron will drive R&D activities in the country and help meet the demand for isotopes.
Key players tend to undertake strategic initiatives such as collaborations, licensing, and partnerships to adopt new systems that can reduce cost and space; such initiatives are expected to drive the market. For instance, in June 2020, Accuray Incorporated launched the CyberKnife S7 System, which offers advanced technologies including real-time AI-driven motion tracking and synchronized treatment delivery. It can provide all SBRT treatments and Stereotactic Radio Surgeries (SRS) within 15 minutes.
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
Chapter 4 Market Definitions
Chapter 5 Industry Outlook
5.1 Key Opportunities Prioritized
5.2 Market Dynamics
5.2.1 Rising Adoption Of Radiotherapy
5.2.2 Technological Advancements In Radiotherapy
5.2.3 Rising Prevalence Of Cancer
5.2.4 Increase In Healthcare Expenditure
5.2.5 Favorable Reimbursement Scenario
5.3 Market Restraint Analysis
5.3.1 Lack Of Skilled Radiotherapy Professionals
5.3.2 Adverse Effects Of Radiotherapy
5.4 Swot Analysis; By Factor (Political & Legal, Economic and Technological)
5.5 Porter's Five Forces Analysis
5.6 Regulatory Framework
Chapter 6 The U.S. Radiation Oncology Market-Segment Analysis, By Type, 2016-2027 (USD Million)(Volume, Number Of Units)
6.1 The U.S. Radiation Oncology Market: Type Movement Analysis
6.2 External Beam Radiation Therapy
6.2.1 External Beam Radiation Therapy Market, 2016-2027 (USD Million)
6.2.2 external Beam Radiation Therapy Market, 2016-2027 (Volume, Number Of Units)
6.2.3 Electron-Emitting High Energy Linear Accelerators
6.2.3.1 Electron-Emitting High Energy Linear Accelerators Market, 2016-2027 (USD Million)
6.2.3.2 Electron-Emitting High Energy Linear Accelerators Market, 2016-2027 (Volume, Number Of Units)
6.2.4 Compact Advanced Radiotherapy Systems
6.2.4.1 Compact Advanced Radiotherapy Systems Market, 2016-2027 (USD Million)
6.2.4.2 Compact Advanced Radiotherapy Systems Market, 2016-2027 (Volume, Number Of Units)
6.2.4.3 Cyberknife
6.2.4.4 Gamma Knife
6.2.4.5 Tomotherapy
6.2.5 Proton Therapy
6.2.5.1 Proton Therapy Market, 2016-2027 (USD Million)
6.2.5.2 Proton Therapy Market, 2016-2027 (Volume, Number Of Units)
6.2.5.3 Cyclotron
6.2.5.4 Synchrotron
6.3 Internal Beam Radiation Therapy
6.3.1 Internal Beam Radiation Therapy Market, 2016-2027 (USD Million)
6.3.2 Internal Beam Radiation Therapy Market, 2016-2027 (Volume, Number Of Units)
6.3.3 Brachytherapy
6.3.3.1 Brachytherapy Market, 2016-2027 (USD Million)
6.3.3.2 Brachytherapy Market, 2016-2027 (Volume, Number Of Units)
6.3.3.3 Seeds
6.3.3.4 Applicators and After-Loaders
6.3.3.4 Electronic Brachytherapy
6.3.4 Systemic Beam Radiation Therapy
6.3.3.2 Brachytherapy Market, 2016-2027 (Volume, Number Of Units)
Chapter 7 The U.S. Radiation Oncology Market-Segment Analysis, By Technology, 2016-2027 (USD Million)(Volume, Number Of Units)
7.1 The U.S. Radiation Oncology Market: Technology Movement Analysis
7.2 External Beam Radiation Therapy (Ebrt)
7.2.1 Ebrt Market, 2016-2027 (USD Million)
7.2.2 Ebrt Market, 2016-2027 (Volume, Number Of Procedures)
7.2.3 Image-Guided Radiation Therapy (Igrt)
7.2.4 Intensity Modulated Radiotherapy (Imrt)
7.2.5 Stereotactic Radiotherapy
7.2.6 Proton Beam Therapy
7.2.7 3d Conformal Radiotherapy (3d-Crt)
7.2.8 Volumetric Modulated Arc Therapy (Vmat)
7.3 Brachytherapy
7.3.1 Brachytherapy Market, 2016-2027 (USD Million)
7.3.2 Brachytherapy Market, 2016-2027 (Volume, Number Of Units)
7.3.3 Low Dose Rate (Ldr) Brachytherapy
7.3.4 High Dose Rate (Hdr) Brachytherapy
Chapter 8 The U.S. Radiation Oncology Market-Segment Analysis, By Application, 2016-2027 (USD Million)(Volume, Number Of Procedures)
8.1 The U.S. Radiation Oncology Market: Application Movement Analysis
8.2 External Beam Radiation Therapy (Ebrt)
8.2.1 Prostate Cancer
8.2.2 Breast Cancer
8.2.3 Lung Cancer
8.2.4 Head and Neck Cancer
8.2.5 Colorectal cancer
8.3 Internal Beam Radiation Therapy
8.3.1 Prostate Cancer
8.3.2 Gynecologic Cancer
8.3.3 Breast Cancer
8.3.4 Cervical Cancer
8.3.5 Penile Cancer
Chapter 9 Competitive Landscape
9.1 Strategic Framework
9.2 Company Profiles
- Varian Medical Systems, Inc.
- Elekta Ab
- Accuray Inc.
- C.R. Bard, Inc.
- Mevion Medical Systems
- Ion Beam Applications (Iba).
- Curium
- Nordion Inc.
For more information about this report visit https://www.researchandmarkets.com/r/vcn7c
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.